Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Differences in the Associations between Memory Complaints and Depressive Symptoms among Black and White Older Adults.

Hill NL, Mogle J, Bhargava S, Whitaker E, Bhang IY, Capuano AW, Arvanitakis Z, Bennett DA, Barnes LL.

J Gerontol B Psychol Sci Soc Sci. 2018 Aug 9. doi: 10.1093/geronb/gby091. [Epub ahead of print]

PMID:
30102393
2.

Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology.

Arvanitakis Z, Capuano AW, Lamar M, Shah RC, Barnes LL, Bennett DA, Schneider JA.

Neurology. 2018 Aug 7;91(6):e517-e525. doi: 10.1212/WNL.0000000000005951. Epub 2018 Jul 11.

PMID:
29997190
3.

Watershed microinfarct pathology and cognition in older persons.

Kapasi A, Leurgans SE, James BD, Boyle PA, Arvanitakis Z, Nag S, Bennett DA, Buchman AS, Schneider JA.

Neurobiol Aging. 2018 May 30;70:10-17. doi: 10.1016/j.neurobiolaging.2018.05.027. [Epub ahead of print]

PMID:
29935416
4.

Association of Financial Literacy With Hospitalization in Community-dwelling Older Adults.

James BD, Wilson RS, Shah RC, Yu L, Arvanitakis Z, Bennett DA, Boyle PA.

Med Care. 2018 Jul;56(7):596-602. doi: 10.1097/MLR.0000000000000932.

PMID:
29901572
5.

Memory complaints, dementia, and neuropathology in older blacks and whites.

Arvanitakis Z, Leurgans SE, Fleischman DA, Schneider JA, Rajan KB, Pruzin JJ, Shah RC, Evans DA, Barnes LL, Bennett DA.

Ann Neurol. 2018 Apr;83(4):718-729. doi: 10.1002/ana.25189. Epub 2018 Mar 30.

PMID:
29466839
6.

Review: Relationship of type 2 diabetes to human brain pathology.

Pruzin JJ, Nelson PT, Abner EL, Arvanitakis Z.

Neuropathol Appl Neurobiol. 2018 Jun;44(4):347-362. doi: 10.1111/nan.12476. Epub 2018 Mar 4. Review.

PMID:
29424027
7.

Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.

Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, Craft S, Gandy S, Buettner C, Stoeckel LE, Holtzman DM, Nathan DM.

Nat Rev Neurol. 2018 Mar;14(3):168-181. doi: 10.1038/nrneurol.2017.185. Epub 2018 Jan 29. Review.

PMID:
29377010
8.

Diabetes is Not Associated with Alzheimer's Disease Neuropathology.

Dos Santos Matioli MNP, Suemoto CK, Rodriguez RD, Farias DS, da Silva MM, Leite REP, Ferretti-Rebustini REL, Farfel JM, Pasqualucci CA, Jacob Filho W, Arvanitakis Z, Naslavsky MS, Zatz M, Grinberg LT, Nitrini R.

J Alzheimers Dis. 2017;60(3):1035-1043. doi: 10.3233/JAD-170179.

9.

Body Mass Index and Decline in Cognitive Function in Older Black and White Persons.

Arvanitakis Z, Capuano AW, Bennett DA, Barnes LL.

J Gerontol A Biol Sci Med Sci. 2018 Jan 16;73(2):198-203. doi: 10.1093/gerona/glx152.

PMID:
28961897
10.

Purpose in Life and Hospitalization for Ambulatory Care-Sensitive Conditions in Old Age.

Wilson RS, Capuano AW, James BD, Amofa P, Arvanitakis Z, Shah R, Bennett DA, Boyle PA.

Am J Geriatr Psychiatry. 2018 Mar;26(3):364-374. doi: 10.1016/j.jagp.2017.06.022. Epub 2017 Jun 30.

PMID:
28780129
11.

Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology.

Yarchoan M, James BD, Shah RC, Arvanitakis Z, Wilson RS, Schneider J, Bennett DA, Arnold SE.

J Alzheimers Dis. 2017;56(2):699-706. doi: 10.3233/JAD-160977.

12.

Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology.

Pruzin JJ, Schneider JA, Capuano AW, Leurgans SE, Barnes LL, Ahima RS, Arnold SE, Bennett DA, Arvanitakis Z.

Alzheimer Dis Assoc Disord. 2017 Jan-Mar;31(1):41-47. doi: 10.1097/WAD.0000000000000172.

13.

White matter hyperintensities, incident mild cognitive impairment, and cognitive decline in old age.

Boyle PA, Yu L, Fleischman DA, Leurgans S, Yang J, Wilson RS, Schneider JA, Arvanitakis Z, Arfanakis K, Bennett DA.

Ann Clin Transl Neurol. 2016 Sep 1;3(10):791-800. eCollection 2016 Oct.

14.

Cognitive decline following incident and preexisting diabetes mellitus in a population sample.

Rajan KB, Arvanitakis Z, Lynch EB, McAninch EA, Wilson RS, Weuve J, Barnes LL, Bianco AC, Evans DA.

Neurology. 2016 Oct 18;87(16):1681-1687. Epub 2016 Sep 21.

15.

Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study.

Arvanitakis Z, Capuano AW, Leurgans SE, Bennett DA, Schneider JA.

Lancet Neurol. 2016 Aug;15(9):934-943. doi: 10.1016/S1474-4422(16)30029-1. Epub 2016 Jun 14.

16.

Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction.

Stoeckel LE, Arvanitakis Z, Gandy S, Small D, Kahn CR, Pascual-Leone A, Pawlyk A, Sherwin R, Smith P.

Version 2. F1000Res. 2016 Mar 15 [revised 2016 Jan 1];5:353. doi: 10.12688/f1000research.8300.2. eCollection 2016. Review.

17.

The Relationship of Cerebral Vessel Pathology to Brain Microinfarcts.

Arvanitakis Z, Capuano AW, Leurgans SE, Buchman AS, Bennett DA, Schneider JA.

Brain Pathol. 2017 Jan;27(1):77-85. doi: 10.1111/bpa.12365. Epub 2016 Apr 14.

18.

Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology.

Abner EL, Nelson PT, Kryscio RJ, Schmitt FA, Fardo DW, Woltjer RL, Cairns NJ, Yu L, Dodge HH, Xiong C, Masaki K, Tyas SL, Bennett DA, Schneider JA, Arvanitakis Z.

Alzheimers Dement. 2016 Aug;12(8):882-9. doi: 10.1016/j.jalz.2015.12.006. Epub 2016 Jan 23.

19.

Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant.

Felsky D, De Jager PL, Schneider JA, Arfanakis K, Fleischman DA, Arvanitakis Z, Honer WG, Pouget JG, Mizrahi R, Pollock BG, Kennedy JL, Bennett DA, Voineskos AN; authors of the Alzheimer’s Disease Neuroimaging Initiative.

J Cereb Blood Flow Metab. 2016 Apr;36(4):819-30. doi: 10.1177/0271678X15626719. Epub 2016 Jan 13.

20.

APOE and cerebral amyloid angiopathy in community-dwelling older persons.

Yu L, Boyle PA, Nag S, Leurgans S, Buchman AS, Wilson RS, Arvanitakis Z, Farfel JM, De Jager PL, Bennett DA, Schneider JA.

Neurobiol Aging. 2015 Nov;36(11):2946-2953. doi: 10.1016/j.neurobiolaging.2015.08.008. Epub 2015 Aug 15.

21.

Mixed pathology is more likely in black than white decedents with Alzheimer dementia.

Barnes LL, Leurgans S, Aggarwal NT, Shah RC, Arvanitakis Z, James BD, Buchman AS, Bennett DA, Schneider JA.

Neurology. 2015 Aug 11;85(6):528-34. doi: 10.1212/WNL.0000000000001834. Epub 2015 Jul 15.

22.

Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment.

Arvanitakis Z, Fleischman DA, Arfanakis K, Leurgans SE, Barnes LL, Bennett DA.

Brain Struct Funct. 2016 May;221(4):2135-46. doi: 10.1007/s00429-015-1034-7. Epub 2015 Apr 2.

23.

Physical activity, motor function, and white matter hyperintensity burden in healthy older adults.

Fleischman DA, Yang J, Arfanakis K, Arvanitakis Z, Leurgans SE, Turner AD, Barnes LL, Bennett DA, Buchman AS.

Neurology. 2015 Mar 31;84(13):1294-300. doi: 10.1212/WNL.0000000000001417. Epub 2015 Mar 11.

24.

Relation of antiphospholipid antibodies to postmortem brain infarcts in older people.

Arvanitakis Z, Brey RL, Rand JH, Schneider JA, Capuano AW, Yu L, Leurgans SE, Bennett DA, Levine SR.

Circulation. 2015 Jan 13;131(2):182-9. doi: 10.1161/CIRCULATIONAHA.114.012479. Epub 2014 Oct 9.

25.

Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies.

Yarchoan M, Toledo JB, Lee EB, Arvanitakis Z, Kazi H, Han LY, Louneva N, Lee VM, Kim SF, Trojanowski JQ, Arnold SE.

Acta Neuropathol. 2014 Nov;128(5):679-89. doi: 10.1007/s00401-014-1328-5. Epub 2014 Aug 9.

26.

Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues.

Song W, Zukor H, Liberman A, Kaduri S, Arvanitakis Z, Bennett DA, Schipper HM.

Exp Neurol. 2014 Apr;254:78-89. doi: 10.1016/j.expneurol.2014.01.006. Epub 2014 Jan 15.

27.

Gray-matter macrostructure in cognitively healthy older persons: associations with age and cognition.

Fleischman DA, Leurgans S, Arfanakis K, Arvanitakis Z, Barnes LL, Boyle PA, Han SD, Bennett DA.

Brain Struct Funct. 2014 Nov;219(6):2029-49. doi: 10.1007/s00429-013-0622-7. Epub 2013 Aug 17.

28.

Faster cognitive decline in the years prior to MR imaging is associated with smaller hippocampal volumes in cognitively healthy older persons.

Fleischman DA, Yu L, Arfanakis K, Han SD, Barnes LL, Arvanitakis Z, Boyle PA, Bennett DA.

Front Aging Neurosci. 2013 Jun 5;5:21. doi: 10.3389/fnagi.2013.00021. eCollection 2013.

29.

Apolipoprotein E and change in episodic memory in blacks and whites.

Barnes LL, Arvanitakis Z, Yu L, Kelly J, De Jager PL, Bennett DA.

Neuroepidemiology. 2013;40(3):211-9. doi: 10.1159/000342778. Epub 2013 Jan 24.

30.

Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease.

Ferman TJ, Arvanitakis Z, Fujishiro H, Duara R, Parfitt F, Purdy M, Waters C, Barker W, Graff-Radford NR, Dickson DW.

Parkinsonism Relat Disord. 2013 Feb;19(2):227-31. doi: 10.1016/j.parkreldis.2012.10.013. Epub 2012 Nov 20.

31.

Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study.

Arvanitakis Z, Brey RL, Rand JH, Schneider JA, Leurgans SE, Yu L, Buchman AS, Arfanakis K, Fleischman DA, Boyle PA, Bennett DA, Levine SR.

Neuroepidemiology. 2013;40(2):73-84. doi: 10.1159/000342761. Epub 2012 Oct 24.

32.

Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.

Schneider JA, Arvanitakis Z, Yu L, Boyle PA, Leurgans SE, Bennett DA.

Brain. 2012 Oct;135(Pt 10):3005-14. doi: 10.1093/brain/aws234.

33.

Selected findings from the Religious Orders Study and Rush Memory and Aging Project.

Bennett DA, Wilson RS, Arvanitakis Z, Boyle PA, de Toledo-Morrell L, Schneider JA.

J Alzheimers Dis. 2013;33 Suppl 1:S397-403. doi: 10.3233/JAD-2012-129007. Review.

34.

Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.

Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE.

J Clin Invest. 2012 Apr;122(4):1316-38. doi: 10.1172/JCI59903.

35.

Overview and findings from the religious orders study.

Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS.

Curr Alzheimer Res. 2012 Jul;9(6):628-45.

36.

Cerebral amyloid angiopathy pathology and cognitive domains in older persons.

Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA.

Ann Neurol. 2011 Feb;69(2):320-7. doi: 10.1002/ana.22112. Epub 2010 Nov 8.

37.

Microinfarct pathology, dementia, and cognitive systems.

Arvanitakis Z, Leurgans SE, Barnes LL, Bennett DA, Schneider JA.

Stroke. 2011 Mar;42(3):722-7. doi: 10.1161/STROKEAHA.110.595082. Epub 2011 Jan 6.

38.

Clinical trial efforts in Alzheimer disease: why test statins?

Arvanitakis Z, Knopman DS.

Neurology. 2010 Mar 23;74(12):945-6. doi: 10.1212/WNL.0b013e3181d6479a. Epub 2010 Mar 3. No abstract available.

PMID:
20200345
39.

Parkinsonian signs and incident falls in older persons without Parkinson's disease.

Buracchio T, Arvanitakis Z, Leurgans S, Bennett DA.

J Am Geriatr Soc. 2010 Jan;58(1):205-6. doi: 10.1111/j.1532-5415.2009.02657.x. No abstract available.

40.

Update on frontotemporal dementia.

Arvanitakis Z.

Neurologist. 2010 Jan;16(1):16-22. doi: 10.1097/NRL.0b013e3181b1d5c6. Review.

41.

The neuropathology of probable Alzheimer disease and mild cognitive impairment.

Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA.

Ann Neurol. 2009 Aug;66(2):200-8. doi: 10.1002/ana.21706.

42.

Diabetes and cognitive systems in older black and white persons.

Arvanitakis Z, Bennett DA, Wilson RS, Barnes LL.

Alzheimer Dis Assoc Disord. 2010 Jan-Mar;24(1):37-42. doi: 10.1097/WAD.0b013e3181a6bed5.

43.

Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1.

Hascalovici JR, Vaya J, Khatib S, Holcroft CA, Zukor H, Song W, Arvanitakis Z, Bennett DA, Schipper HM.

J Neurochem. 2009 Aug;110(4):1241-53. doi: 10.1111/j.1471-4159.2009.06213.x. Epub 2009 Jun 9.

44.

Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology.

Arvanitakis Z, Grodstein F, Bienias JL, Schneider JA, Wilson RS, Kelly JF, Evans DA, Bennett DA.

Neurology. 2008 Jun 3;70(23):2219-25. doi: 10.1212/01.wnl.0000313813.48505.86.

PMID:
18519870
45.

Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.

Arvanitakis Z, Schneider JA, Wilson RS, Bienias JL, Kelly JF, Evans DA, Bennett DA.

Neurology. 2008 May 6;70(19 Pt 2):1795-802. doi: 10.1212/01.wnl.0000288181.00826.63. Epub 2008 Jan 16.

PMID:
18199831
46.

Mixed brain pathologies account for most dementia cases in community-dwelling older persons.

Schneider JA, Arvanitakis Z, Bang W, Bennett DA.

Neurology. 2007 Dec 11;69(24):2197-204. Epub 2007 Jun 13.

PMID:
17568013
47.

Diabetes and parkinsonian signs in older persons.

Arvanitakis Z, Wilson RS, Bienias JL, Bennett DA.

Alzheimer Dis Assoc Disord. 2007 Apr-Jun;21(2):144-9.

PMID:
17545740
48.

Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons.

Schneider JA, Boyle PA, Arvanitakis Z, Bienias JL, Bennett DA.

Ann Neurol. 2007 Jul;62(1):59-66.

PMID:
17503514
49.

Lower extremity motor function and disability in mild cognitive impairment.

Boyle PA, Wilson RS, Buchman AS, Aggarwal NT, Tang Y, Arvanitakis Z, Kelly J, Bennett DA.

Exp Aging Res. 2007 Jul-Sep;33(3):355-71.

PMID:
17497375
50.

Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment.

Assaraf MI, Diaz Z, Liberman A, Miller WH Jr, Arvanitakis Z, Li Y, Bennett DA, Schipper HM.

J Neuropathol Exp Neurol. 2007 May;66(5):389-98.

PMID:
17483696

Supplemental Content

Loading ...
Support Center